Review



elisa kit pathscan acetylated histone h3 sandwich elisa kit #7232  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Cell Signaling Technology Inc elisa kit pathscan acetylated histone h3 sandwich elisa kit #7232
    Elisa Kit Pathscan Acetylated Histone H3 Sandwich Elisa Kit #7232, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/elisa kit pathscan acetylated histone h3 sandwich elisa kit #7232/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    elisa kit pathscan acetylated histone h3 sandwich elisa kit #7232 - by Bioz Stars, 2026-03
    90/100 stars

    Images



    Similar Products

    elisa kit pathscan acetylated histone h3 sandwich elisa kit #7232  (Cell Signaling Technology Inc)
    90
    Cell Signaling Technology Inc elisa kit pathscan acetylated histone h3 sandwich elisa kit #7232
    Elisa Kit Pathscan Acetylated Histone H3 Sandwich Elisa Kit #7232, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/elisa kit pathscan acetylated histone h3 sandwich elisa kit #7232/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    elisa kit pathscan acetylated histone h3 sandwich elisa kit #7232 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    resource source identifier antibodies histone h3 d1h2 xp rabbit mab cell signaling technology  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc resource source identifier antibodies histone h3 d1h2 xp rabbit mab cell signaling technology
    Resource Source Identifier Antibodies Histone H3 D1h2 Xp Rabbit Mab Cell Signaling Technology, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/resource source identifier antibodies histone h3 d1h2 xp rabbit mab cell signaling technology/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    resource source identifier antibodies histone h3 d1h2 xp rabbit mab cell signaling technology - by Bioz Stars, 2026-03
    96/100 stars
    		  Buy from Supplier
    c36b21 rabbit mab  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc c36b21 rabbit mab
    C36b21 Rabbit Mab, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c36b21 rabbit mab/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    c36b21 rabbit mab - by Bioz Stars, 2026-03
    96/100 stars
    		  Buy from Supplier
    pathscan total stat3 sandwich elisa kit  (Cell Signaling Technology Inc)
    90
    Cell Signaling Technology Inc pathscan total stat3 sandwich elisa kit
    Development of A5, a novel PAI-1–neutralizing antibody. A, Graphical illustration of phage screen and identification of PAI-1–neutralizing antibody. B, Recognition of different conformations of recombinant PAI-1 by A5 in Western blotting. C, A5 neutralized PAI-1 function in inhibiting tPA and uPA. D, Competitive binding of A5 with fluorine-containing tiplaxtinin on stable active PAI-1 assessed by 19F-NMR. E, Inhibition of proliferation of PM cells treated with PAI-1–positive ascites in vitro by 150 µg/mL A5 in biological triplicates. Human IgG served as a negative control. F, <t>STAT3</t> signaling activation upon the exposure to PM ascites was suppressed by A5 as compared with IgG control. G, GSEA comparisons of HALLMARK pathway changes between CRC cells treated with A5 ( n = 2) vs. IgG ( n = 2). Pathways with an FDR adjusted P value of less than 0.05 are opacified. CRC, colorectal cancer; NES, normalized enrichment score.
    Pathscan Total Stat3 Sandwich Elisa Kit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pathscan total stat3 sandwich elisa kit/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    pathscan total stat3 sandwich elisa kit - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    pathscan acetylated histone h3 sandwich elisa kit  (Cell Signaling Technology Inc)
    90
    Cell Signaling Technology Inc pathscan acetylated histone h3 sandwich elisa kit
    Development of A5, a novel PAI-1–neutralizing antibody. A, Graphical illustration of phage screen and identification of PAI-1–neutralizing antibody. B, Recognition of different conformations of recombinant PAI-1 by A5 in Western blotting. C, A5 neutralized PAI-1 function in inhibiting tPA and uPA. D, Competitive binding of A5 with fluorine-containing tiplaxtinin on stable active PAI-1 assessed by 19F-NMR. E, Inhibition of proliferation of PM cells treated with PAI-1–positive ascites in vitro by 150 µg/mL A5 in biological triplicates. Human IgG served as a negative control. F, <t>STAT3</t> signaling activation upon the exposure to PM ascites was suppressed by A5 as compared with IgG control. G, GSEA comparisons of HALLMARK pathway changes between CRC cells treated with A5 ( n = 2) vs. IgG ( n = 2). Pathways with an FDR adjusted P value of less than 0.05 are opacified. CRC, colorectal cancer; NES, normalized enrichment score.
    Pathscan Acetylated Histone H3 Sandwich Elisa Kit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pathscan acetylated histone h3 sandwich elisa kit/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    pathscan acetylated histone h3 sandwich elisa kit - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    pathscan phospho stat3 sandwich elisa kit  (Cell Signaling Technology Inc)
    94
    Cell Signaling Technology Inc pathscan phospho stat3 sandwich elisa kit
    Development of A5, a novel PAI-1–neutralizing antibody. A, Graphical illustration of phage screen and identification of PAI-1–neutralizing antibody. B, Recognition of different conformations of recombinant PAI-1 by A5 in Western blotting. C, A5 neutralized PAI-1 function in inhibiting tPA and uPA. D, Competitive binding of A5 with fluorine-containing tiplaxtinin on stable active PAI-1 assessed by 19F-NMR. E, Inhibition of proliferation of PM cells treated with PAI-1–positive ascites in vitro by 150 µg/mL A5 in biological triplicates. Human IgG served as a negative control. F, <t>STAT3</t> signaling activation upon the exposure to PM ascites was suppressed by A5 as compared with IgG control. G, GSEA comparisons of HALLMARK pathway changes between CRC cells treated with A5 ( n = 2) vs. IgG ( n = 2). Pathways with an FDR adjusted P value of less than 0.05 are opacified. CRC, colorectal cancer; NES, normalized enrichment score.
    Pathscan Phospho Stat3 Sandwich Elisa Kit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pathscan phospho stat3 sandwich elisa kit/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    pathscan phospho stat3 sandwich elisa kit - by Bioz Stars, 2026-03
    94/100 stars
    		  Buy from Supplier
    pathscan rp phospho irf 3 ser379 sandwich elisa kit  (Cell Signaling Technology Inc)
    94
    Cell Signaling Technology Inc pathscan rp phospho irf 3 ser379 sandwich elisa kit
    Development of A5, a novel PAI-1–neutralizing antibody. A, Graphical illustration of phage screen and identification of PAI-1–neutralizing antibody. B, Recognition of different conformations of recombinant PAI-1 by A5 in Western blotting. C, A5 neutralized PAI-1 function in inhibiting tPA and uPA. D, Competitive binding of A5 with fluorine-containing tiplaxtinin on stable active PAI-1 assessed by 19F-NMR. E, Inhibition of proliferation of PM cells treated with PAI-1–positive ascites in vitro by 150 µg/mL A5 in biological triplicates. Human IgG served as a negative control. F, <t>STAT3</t> signaling activation upon the exposure to PM ascites was suppressed by A5 as compared with IgG control. G, GSEA comparisons of HALLMARK pathway changes between CRC cells treated with A5 ( n = 2) vs. IgG ( n = 2). Pathways with an FDR adjusted P value of less than 0.05 are opacified. CRC, colorectal cancer; NES, normalized enrichment score.
    Pathscan Rp Phospho Irf 3 Ser379 Sandwich Elisa Kit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pathscan rp phospho irf 3 ser379 sandwich elisa kit/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    pathscan rp phospho irf 3 ser379 sandwich elisa kit - by Bioz Stars, 2026-03
    94/100 stars
    		  Buy from Supplier
    pathscan ar elisa  (Cell Signaling Technology Inc)
    94
    Cell Signaling Technology Inc pathscan ar elisa
    Development of A5, a novel PAI-1–neutralizing antibody. A, Graphical illustration of phage screen and identification of PAI-1–neutralizing antibody. B, Recognition of different conformations of recombinant PAI-1 by A5 in Western blotting. C, A5 neutralized PAI-1 function in inhibiting tPA and uPA. D, Competitive binding of A5 with fluorine-containing tiplaxtinin on stable active PAI-1 assessed by 19F-NMR. E, Inhibition of proliferation of PM cells treated with PAI-1–positive ascites in vitro by 150 µg/mL A5 in biological triplicates. Human IgG served as a negative control. F, <t>STAT3</t> signaling activation upon the exposure to PM ascites was suppressed by A5 as compared with IgG control. G, GSEA comparisons of HALLMARK pathway changes between CRC cells treated with A5 ( n = 2) vs. IgG ( n = 2). Pathways with an FDR adjusted P value of less than 0.05 are opacified. CRC, colorectal cancer; NES, normalized enrichment score.
    Pathscan Ar Elisa, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pathscan ar elisa/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    pathscan ar elisa - by Bioz Stars, 2026-03
    94/100 stars
    		  Buy from Supplier
    phospho p38 mapk thr180 tyr182 sandwich elisa kit  (Cell Signaling Technology Inc)
    94
    Cell Signaling Technology Inc phospho p38 mapk thr180 tyr182 sandwich elisa kit
    Development of A5, a novel PAI-1–neutralizing antibody. A, Graphical illustration of phage screen and identification of PAI-1–neutralizing antibody. B, Recognition of different conformations of recombinant PAI-1 by A5 in Western blotting. C, A5 neutralized PAI-1 function in inhibiting tPA and uPA. D, Competitive binding of A5 with fluorine-containing tiplaxtinin on stable active PAI-1 assessed by 19F-NMR. E, Inhibition of proliferation of PM cells treated with PAI-1–positive ascites in vitro by 150 µg/mL A5 in biological triplicates. Human IgG served as a negative control. F, <t>STAT3</t> signaling activation upon the exposure to PM ascites was suppressed by A5 as compared with IgG control. G, GSEA comparisons of HALLMARK pathway changes between CRC cells treated with A5 ( n = 2) vs. IgG ( n = 2). Pathways with an FDR adjusted P value of less than 0.05 are opacified. CRC, colorectal cancer; NES, normalized enrichment score.
    Phospho P38 Mapk Thr180 Tyr182 Sandwich Elisa Kit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phospho p38 mapk thr180 tyr182 sandwich elisa kit/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    phospho p38 mapk thr180 tyr182 sandwich elisa kit - by Bioz Stars, 2026-03
    94/100 stars
    		  Buy from Supplier
    western blot cell signaling technology cat  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc western blot cell signaling technology cat
    Development of A5, a novel PAI-1–neutralizing antibody. A, Graphical illustration of phage screen and identification of PAI-1–neutralizing antibody. B, Recognition of different conformations of recombinant PAI-1 by A5 in Western blotting. C, A5 neutralized PAI-1 function in inhibiting tPA and uPA. D, Competitive binding of A5 with fluorine-containing tiplaxtinin on stable active PAI-1 assessed by 19F-NMR. E, Inhibition of proliferation of PM cells treated with PAI-1–positive ascites in vitro by 150 µg/mL A5 in biological triplicates. Human IgG served as a negative control. F, <t>STAT3</t> signaling activation upon the exposure to PM ascites was suppressed by A5 as compared with IgG control. G, GSEA comparisons of HALLMARK pathway changes between CRC cells treated with A5 ( n = 2) vs. IgG ( n = 2). Pathways with an FDR adjusted P value of less than 0.05 are opacified. CRC, colorectal cancer; NES, normalized enrichment score.
    Western Blot Cell Signaling Technology Cat, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/western blot cell signaling technology cat/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    western blot cell signaling technology cat - by Bioz Stars, 2026-03
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    Development of A5, a novel PAI-1–neutralizing antibody. A, Graphical illustration of phage screen and identification of PAI-1–neutralizing antibody. B, Recognition of different conformations of recombinant PAI-1 by A5 in Western blotting. C, A5 neutralized PAI-1 function in inhibiting tPA and uPA. D, Competitive binding of A5 with fluorine-containing tiplaxtinin on stable active PAI-1 assessed by 19F-NMR. E, Inhibition of proliferation of PM cells treated with PAI-1–positive ascites in vitro by 150 µg/mL A5 in biological triplicates. Human IgG served as a negative control. F, STAT3 signaling activation upon the exposure to PM ascites was suppressed by A5 as compared with IgG control. G, GSEA comparisons of HALLMARK pathway changes between CRC cells treated with A5 ( n = 2) vs. IgG ( n = 2). Pathways with an FDR adjusted P value of less than 0.05 are opacified. CRC, colorectal cancer; NES, normalized enrichment score.

    Journal: Clinical Cancer Research

    Article Title: Spatial Heterogeneity, Stromal Phenotypes, and Therapeutic Vulnerabilities in Colorectal Cancer Peritoneal Metastasis

    doi: 10.1158/1078-0432.CCR-24-3780

    Figure Lengend Snippet: Development of A5, a novel PAI-1–neutralizing antibody. A, Graphical illustration of phage screen and identification of PAI-1–neutralizing antibody. B, Recognition of different conformations of recombinant PAI-1 by A5 in Western blotting. C, A5 neutralized PAI-1 function in inhibiting tPA and uPA. D, Competitive binding of A5 with fluorine-containing tiplaxtinin on stable active PAI-1 assessed by 19F-NMR. E, Inhibition of proliferation of PM cells treated with PAI-1–positive ascites in vitro by 150 µg/mL A5 in biological triplicates. Human IgG served as a negative control. F, STAT3 signaling activation upon the exposure to PM ascites was suppressed by A5 as compared with IgG control. G, GSEA comparisons of HALLMARK pathway changes between CRC cells treated with A5 ( n = 2) vs. IgG ( n = 2). Pathways with an FDR adjusted P value of less than 0.05 are opacified. CRC, colorectal cancer; NES, normalized enrichment score.

    Article Snippet: Then 25 μg of the protein lysate was used to measure total STAT3 and p-STAT3 (Tyr705) by ELISA using the PathScan Total Stat3 Sandwich ELISA kit (Cell Signaling Technology, 7305C) and the PathScan Phospho-Stat3 (Tyr705) Sandwich ELISA kit (Cell Signaling Technology, 7300C), respectively.

    Techniques: Recombinant, Western Blot, Binding Assay, Inhibition, In Vitro, Negative Control, Activation Assay, Control